Drugging the luminal axis end to end: A review of next-generation endocrine and targeted therapies in HR + /HER2- metastatic breast cancer
European Journal of Cancer · 2026-12 · 249 · 117794
DOI: 10.1016/j.ejca.2026.117794 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift European Journal of Cancer, 2026-12. Verfasst von Aldo Caltavituro und 13 weiteren Autor:innen. Beteiligte Einrichtung: Clinical and Translational Oncology (CTO), Scuola Superiore Meridionale, Napoli, Italy; Translational Genomics and Targeted Therapies in Solid Tumors…. Die Arbeit nennt 104 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Italian Government Ministry of Health.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Clinical and Translational Oncology (CTO), Scuola Superiore Meridionale, Napoli, Italy; Translational Genomics and Targeted Therapies in Solid Tumors, Institut d' Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS),…
- Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA; Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
- Clinical and Translational Oncology (CTO), Scuola Superiore Meridionale, Napoli, Italy; Department of Breast and Thoracic Oncology, Istituto Nazionale Tumori IRCCS - Fondazione G. Pascale, Naples, Italy.
- Clinical and Translational Oncology (CTO), Scuola Superiore Meridionale, Napoli, Italy; Department of Breast and Thoracic Oncology, Istituto Nazionale Tumori IRCCS - Fondazione G. Pascale, Naples, Italy; Breast Cancer T…
- Breast Medical Oncology Unit, IRCCS Humanitas Research Hospital, Milan, Italy; Department of Biomedical Sciences, Humanitas University, Via Rita Levi Montalcinai 4, Pieve Emanuele, Milan, 20072, Italy.
- Translational Genomics and Targeted Therapies in Solid Tumors, Institut d' Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.
Förderung
- Italian Government Ministry of Health
Zitieren
APA
Caltavituro, A., Giordano, A., De Angelis, C., Buonaiuto, R., Canzian, J., Torres-Marcén, M., Schettini, F., Bianchini, G., Salimbeni, B. T., Giuliano, M., Arpino, G., Malorni, L., De Laurentiis, M., & Criscitiello, C. (2026). Drugging the luminal axis end to end: A review of next-generation endocrine and targeted therapies in HR + /HER2- metastatic breast cancer. European Journal of Cancer, 249, 117794. https://doi.org/10.1016/j.ejca.2026.117794
Vancouver
Caltavituro A, Giordano A, De Angelis C, Buonaiuto R, Canzian J, Torres-Marcén M, et al. Drugging the luminal axis end to end: A review of next-generation endocrine and targeted therapies in HR + /HER2- metastatic breast cancer. European Journal of Cancer. 2026;249:117794. doi:10.1016/j.ejca.2026.117794
BibTeX
@article{Caltavituro2026,
author = {Caltavituro, Aldo and Giordano, Antonio and De Angelis, Carmine and Buonaiuto, Roberto and Canzian, Jacopo and Torres-Marcén, Martí and Schettini, Francesco and Bianchini, Giampaolo and Salimbeni, Beatrice Taurelli and Giuliano, Mario and Arpino, Grazia and Malorni, Luca and De Laurentiis, Michelino and Criscitiello, Carmen},
title = {Drugging the luminal axis end to end: A review of next-generation endocrine and targeted therapies in HR + /HER2- metastatic breast cancer},
journal = {European Journal of Cancer},
year = {2026},
volume = {249},
pages = {117794},
doi = {10.1016/j.ejca.2026.117794}
}
EUVIMED